Pharma Times

DECEMBER 14, 2023

The collaboration aims to develop biomarker-based diagnostics for the condition - News - PharmaTimes

Research 144

Research Development 144

Pharma Times

SEPTEMBER 28, 2023

Collaboration will enable teams across the organisation to increase clinical research innovation - News - PharmaTimes

Clinical Research 153

Clinical Research Research 153

Drug Channels

MARCH 17, 2023

Rhiannon discusses the growing collaboration between manufacturers and covered entities regarding 340B discount claims. Today’s guest post comes from Rhiannon Naslund, Chief Marketing Officer at Kalderos. She goes on to describe the Kalderos Discount Hub solution that reviews claims that have a high likelihood of being a duplicate discount.

Manufacturing 81

Manufacturing Drugs Marketing Development 81

BioTech 365

NOVEMBER 3, 2020

Press news Biocartis Group NV: Biocartis and GeneproDx To Collaborate on Fully Automated ThyroidPrint® test on Idylla™ Press news Biocartis Group NV: Biocartis and GeneproDx To Collaborate on Fully Automated ThyroidPrint® test on Idylla™ PRESS RELEASE: 3 November 2020, 07:00 CET … Continue reading →

40

40

Pharma Times

SEPTEMBER 22, 2023

The collaboration will utilise Evaxion’s EDEN-discovered antigen targets - News - PharmaTimes

Development 137

Development Vaccination Vaccine 137

Pharma Times

AUGUST 16, 2023

The collaboration will focus on multiple enzyme cargoes modified using Aliada's modular delivery platform - News - PharmaTimes

105

105

Pharma Times

JULY 14, 2023

Collaboration will focus on progressing test for early detection of Alzheimer’s dementia - News - PharmaTimes

101

101

Pharma Times

JULY 4, 2023

Collaboration aims to revitalise two empty sites on the South Bank of London by providing several laboratories - News - PharmaTimes

98

98

Rethinking Clinical Trials

AUGUST 1, 2023

If you are active on LinkedIn, we invite you to follow our page for the latest news about our innovative Demonstration Projects, tools and resources from the Core Working Groups, upcoming sessions of our weekly Rethinking Clinical Trials Grand Rounds webinar series, and fresh content from the Living Textbook of Pragmatic Clinical Trials.

Clinical Trials 130

Clinical Trials Clinical Trials Research Trials 130

Pharmaceutical Technology

MAY 12, 2023

BioNTech has ended its research collaboration with Matinas after its oral mRNA vaccine failed to demonstrate preclinical activity. Matinas announced the news in a May 10 statement. The news means the collaboration between the two companies lasted just over a year.

Vaccination 130

Vaccination Vaccine In-Vivo In-Vitro 130

Drug Discovery World

AUGUST 11, 2023

News round-up for by DDW Digital Content Editor Diana Spencer. The news headlines this week reflect the level of interest in cell & gene therapies (CGT) in the sector, particularly CAR-T, but also the importance of research collaborations to bring these therapies to patients.

Gene Therapy 52

Gene Therapy Drugs Clinical Trials Clinical Trials 52

Pharmaceutical Technology

MAY 10, 2023

As part of the multi-year collaboration , TScan will receive $30m upfront and a possible $500m in clinical, regulatory, and commercial milestones, in addition to royalty payments. Amgen will retain global development and commercial rights and the option to expand the collaboration to other indications such as ulcerative colitis.

Development 130

Development Marketing Drugs Research 130

BioTech 365

AUGUST 31, 2020

PRESS RELEASE: 1 September 2020, 07:00 CESTBiocartis Expands Collaboration with LifeArc Mechelen, Belgium, and London, UK, 1 September 2020 – Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an innovative molecular diagnostics company (Euronext Brussels: BCART), today announces the expansion of … Continue reading (..)

40

40

Drug Discovery World

SEPTEMBER 8, 2023

News round-up for 4-8 September by DDW Digital Content Editor Diana Spencer. Optibrium acquires BioPharmics AI drug discovery company Optibrium has acquired 3D drug design specialist BioPharmics.

Drugs 52

Drugs Life Science Antibody Licensing 52

BioTech 365

MAY 26, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Open platform SARS-CoV-2 naming system to harness international scientific collaboration.Researchers at the Universities of Oxford and Edinburgh have announced the formalization of the Pango Network, an international … Continue (..)

Research 40

Research 40

Drug Discovery World

MAY 12, 2023

News round-up for 8-12 May by DDW Digital Content Editor Diana Spencer. Inspired by the relaunch of PerkinElmer’s Life Science and Diagnostics business this week as Revvity, my top five news story this week all relate to new drug discovery business developments.

Life Science 52

Life Science Drugs Licensing Licensing 52

Drug Discovery World

OCTOBER 14, 2022

News round-up for 10-14 October by DDW Digital Content Editor Diana Spencer. The top news in the world of drug discovery this week reflects the vital importance of collaboration, partnership and support within this industry. . Collaboration extended in severe neuropsychiatric disorders .

Gene Editing 52

Gene Editing RNA Drugs Gene 52

Drug Discovery World

AUGUST 14, 2023

The news headlines this week reflect the level of interest in cell & gene therapies (CGT) in the sector, particularly CAR-T, but also the importance of research collaborations to bring these therapies to patients.

Gene Therapy 52

Gene Therapy Gene Drugs Marketing 52

Outsourcing Pharma

DECEMBER 21, 2021

This monthâs collaborations, tech partnerships, new facilities, and other happenings includes news from Flywheel, Medable, Veeva, and other organizations.

Regulation 52

Regulation Marketing 52

Drug Discovery World

SEPTEMBER 7, 2023

Sunak said: “The Horizon programme is unrivalled in its scope and opens up a world of opportunity for cooperation on science that delivers real-world benefits for the UK – creating jobs, boosting our economy and opening up collaboration for the sector with some of our closest partners, whether on tackling climate change or advancing cancer research.”

Research 59

Research Scientist Vaccination Vaccine 59

Drug Discovery World

JANUARY 13, 2023

News round-up for 9-13 January by DDW Digital Content Editor Diana Spencer. Once again, research partnerships and licence agreements have dominated the news this week, as drug discovery companies seek new ways to combine their expertise to address unmet medical needs. . The top stories: .

Drugs 52

Drugs Antibody RNA Engineer 52

Drug Discovery World

AUGUST 11, 2023

GenScript Biotech and T-MAXIMUM Biotech have formed a strategic collaboration to develop T-MAXIMUM’s CAR-T cell therapy using GenScript’s CRISPR nucleic acid reagents. We look forward to the further achievements of T-MAXIMUM Biotech’s cell therapy products – and to bringing good news to more patients.”

Reagent 52

Reagent Development Gene Editing Production 52

Drug Discovery World

FEBRUARY 17, 2023

News round-up for 13-17 February by DDW Digital Content Editor Diana Spencer.

Bioinformatics 52

Bioinformatics Drugs Genome Genomics 52

Pharmaceutical Technology

APRIL 19, 2023

This news comes after the refinement of Bayer’s early innovation framework, where it had decided to concentrate on the therapeutic areas with the best opportunities for delivering differentiated, high-value breakthrough medicines to patients.

Gene Therapy 130

Gene Therapy Hormones Production Sales 130

BioTech 365

OCTOBER 29, 2020

PRESS RELEASE: REGULATORY INFORMATION – INSIDE INFORMATION 29 October 2020, 16:45 CET Biocartis and Exact Sciences Agree to End Collaboration Due to Changed Market Circumstances Mechelen, Belgium, 29 October 2020 – Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an innovative … Continue reading →

Marketing 40

Marketing 40

Drug Discovery World

APRIL 5, 2024

News round-up for 1-5 April by DDW Digital Content Editor Diana Spencer. R&D partnership to jointly develop new ALS drugs PrecisionLife and the Nucleic Acid Therapy Accelerator (NATA) have announced a collaboration to co-develop novel oligonucleotide therapies for sporadic motor neurone disease/ALS.

Drugs 52

Drugs Life Science Development Research 52

Drug Discovery World

MARCH 8, 2024

News round-up for 4-8 March by DDW Digital Content Editor Diana Spencer. New R&D collaboration to advance Alport Syndrome programme Fibrocor Therapeutics has entered into a research and development (R&D) collaboration with the McQuade Center for Strategic Research and Development (MSRD) to advance its Alport Syndrome programme.

Antibody 52

Antibody Drugs Clinical Trials Clinical Trials 52

Pharmaceutical Technology

APRIL 4, 2023

On April 4, Scorpion Therapeutics announced a collaboration and license agreement with the French dermo-cosmetic and pharmaceutical group Pierre Fabre to codevelop two next-generation epidermal growth factor receptor (EGFR) inhibitors. STX-241 and STX-721, both target EGFR mutations in non-small cell lung cancer (NSCLC).

Cosmetics 130

Cosmetics Development Licensing Licensing 130

Drug Discovery World

JANUARY 19, 2024

News round-up for 15-19 January by DDW Digital Content Editor Diana Spencer. With seasonal illnesses running amok in the western hemisphere at the moment, it is perhaps not surprising that this week’s news highlights focus on viruses and immunity.

Drugs 52

Drugs Vaccination Vaccine Genetics 52

Drug Discovery World

DECEMBER 12, 2022

DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry news. . Teamwork makes the dream work’ this week, with the launch of new partnerships to further the development of precision drugs in neurodevelopmental disorders, lung cancer and rare paediatric diseases.

Drugs 52

Drugs Vaccination Vaccine Development 52

Drug Discovery World

AUGUST 12, 2022

News round-up by DDW’s Reece Armstrong for 8-12 August . New insights into melanoma, a company transition into life sciences and a Lyme disease vaccine are some of the stories in this week’s news round-up. Pfizer launches Phase III trial for Lyme disease vaccine?? .

Life Science 52

Life Science Drugs Vaccination Vaccine 52

The Pharma Data

NOVEMBER 13, 2020

Outcomes Vary for Depression Collaborative Care Programs. 13, 2020 — Real-world collaborative care programs for depression show large variation in clinical outcomes, according to a study published in the November issue of Health Affairs. More News Resources. Professional. FRIDAY, Nov. Jürgen Unützer, M.D., Source link.

Trials 52

Trials Research 52

Drug Discovery World

AUGUST 14, 2023

The news headlines this week reflect the level of interest in cell & gene therapies (CGT) in the sector, particularly CAR-T, but also the importance of research collaborations to bring these therapies to patients.

Gene Therapy 52

Gene Therapy Gene Drugs Marketing 52

BioTech 365

JUNE 27, 2021

Waters to Help Accelerate Biologics Production Through Research Collaboration With Singapore’s Bioprocessing Technology Institute Waters to Help Accelerate Biologics Production Through Research Collaboration With Singapore’s Bioprocessing Technology Institute Project Explores LC-MS Data Analytics Methods to Rapidly Characterize Complex Biomolecules (..)

Production 52

Production Research 52

BioTech 365

APRIL 25, 2021

DGAP-News: Evotec SE / Key word(s): Miscellaneous 26.04.2021 / 07:30 The issuer is solely responsible for the content of this announcement. BRISTOL MYERS SQUIBB EXTENDS COLLABORATION WITH EVOTEC IN THE FIELD OF TARGETED PROTEIN DEGRADATION EXTENSION TRIGGERS AN ADDITIONAL COLLABORATION … Continue reading →

Protein 40

Protein 40

Scienmag

OCTOBER 12, 2021

NEWPORT NEWS, VA – A new measurement of the neutron skin in calcium reveals that heavier types of calcium nuclei are relatively thin-skinned.

Scientist 52

Scientist 52

Drug Discovery World

APRIL 11, 2024

Dr Alison Stillie, Consultant Clinical Oncologist at the Edinburgh Cancer Centre, said: “The SMC’s approval of dostarlimab, in combination with chemotherapy for eligible endometrial cancer patients with dMMR/MSI-H primary advanced or recurrent disease, is welcome news.

Licensing 52

Licensing Licensing Containment Medicine 52